| ID | Sequence | Length | GC content |
|---|---|---|---|
| GGUCCAAACCGGAAGACCGUGGGUAGCUGCGGCGGGGCUGACCCGUCCC… | 3847 nt | 0.6179 | |
| GGUCCAAACCGGAAGACCGUGGGUAGCUGCGGCGGGGCUGACCCGUCCC… | 3481 nt | 0.6176 | |
| GGUCCAAACCGGAAGACCGUGGGUAGCUGCGGCGGGGCUGACCCGUCCC… | 3342 nt | 0.6173 | |
| GGUCCAAACCGGAAGACCGUGGGUAGCUGCGGCGGGGCUGACCCGUCCC… | 3814 nt | 0.6190 | |
| GGUCCAAACCGGAAGACCGUGGGUAGCUGCGGCGGGGCUGACCCGUCCC… | 3659 nt | 0.6166 | |
| GGUCCAAACCGGAAGACCGUGGGUAGCUGCGGCGGGGCUGACCCGUCCC… | 3925 nt | 0.6168 | |
| GGUCCAAACCGGAAGACCGUGGGUAGCUGCGGCGGGGCUGACCCGUCCC… | 3683 nt | 0.6185 |
Initiation of transcription by RNA polymerase I requires the formation of a complex composed of the TATA-binding protein (TBP) and three TBP-associated factors (TAFs) specific for RNA polymerase I. This complex, known as SL1, binds to the core promoter of ribosomal RNA genes to position the polymerase properly and acts as a channel for regulatory signals. This gene encodes the largest SL1-specific TAF. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2011]
A study in humans demonstrated that the TAF1C gene was downregulated as part of the inhibited epigenetic regulation of gene expression pathway specifically in the lungs of patients who succumbed to septic shock [Pinheiro da Silva et al. DOI:10.1111/jcmm.17938].